The pharmacological properties of glutamate agonists were compared in astrocyte-rich and astrocyte-poor cultures derived from embryonic rat cerebral cortex. The object of this investigation was to determine the extent to which glutamate uptake might influence the receptor-mediated neurotoxic actions of these compounds.
The pharmacological properties of glutamate agonists were compared in astrocyte-rich and astrocyte-poor cultures derived from embryonic rat cerebral cortex. The object of this investigation was to determine the extent to which glutamate uptake might influence the receptor-mediated neurotoxic actions of these compounds.
In astrocyte-rich cultures, using 30 min exposures, we observed that the potencies of the poorly transported agonists NMDA (35 PM) and o-glutamate (89 PM) were higher than that of . In astrocyte-poor cultures, L-glutamate was much more potent, with an EC,, of 5 -+ 4 PM (3-l 2 PM), for a 30 min exposure, whereas the potencies of NMDA and o-glutamate were essentially unchanged.
L-and o-aspartate were also more effective in astrocyte-poor cultures, again with EC,, values of approximately 8-10 PM, as compared with 130 and 108 @I, respectively, in astrocyte-rich cultures. In other experiments, blocking sodium-dependent glutamate uptake in astrocyterich cultures, by using a sodium-free medium, made glutamate as potent an agonist as in astrocyte-poor cultures. Finally, we directly assessed the glutamate uptake system in astrocyte-rich and astrocyte-poor cultures and found that uptake was reduced approximately 25-fold in the astrocytepoor cultures.
These results show that in the presence of abundant astrocytes the neurotoxic potencies of L-glutamate, L-aspartate, and o-aspartate are substantially underestimated.
Glutamate neurotoxicity has been proposed as an important mechanism of neuronal injury and death both in acute catastrophic events such as stroke (Choi and Rothman, 1990 ) and trauma (Faden et al., 1989; Tecoma et al., 1989) and in the neuropathological changes associated with chronic neurodegenerative diseases as well (Meldrum and Garthwaite, 1990) . The cellular mechanisms underlying glutamate receptor-mediated neuronal injury and death are not well understood, and the pharmacology of glutamate neurotoxicity is central to our understanding of these mechanisms. Identification of the critical role played by the NMDA receptor, for example, has been im-portant in establishing a role for calcium in glutamate toxicity (Choi and Rothman, 1990) . However, the pathogenic mechanisms that determine when glutamate receptor stimulation will have toxic consequences remain obscure. The intrinsic sensitivity of central neurons to glutamate toxicity is obviously of central importance to understanding the pathogenesis of glutamate receptor-mediated neuronal death.
Previous experiments determined that cortical neurons in tissue culture with reduced numbers of astrocytes present were 100 times more sensitive to a long (18-24 hr) exposure to glutamate than in astrocyte-rich cultures (Rosenberg and Aizenman, 1989) . Glutamate toxicity in astrocyte-poor cultures, as in astrocyte-rich cultures was mediated by NMDA receptors, and yet no difference was observed in the membrane response of neurons cultured under the two sets of conditions to application of NMDA using whole-cell patchclamp recording techniques. These observations suggested two possible explanations: (1) that differences between the two culture systems with respect to access to NMDA receptors on dendrites might explain the difference in apparent potency of glutamate (Garthwaite, 1985) and (2) that differences in the consequences of NMDA receptor stimulation might account for the difference in potency. An example of the latter mechanism is suggested by previous experiments showing the importance of the sodium-calcium exchange in glutamate toxicity in hippocampal cultures (Mattson et al., 1989a) . Differences in the potency of glutamate might be due to differences in the capacity to handle a calcium load in neurons maintained with or without abundant astrocytes (Mattson et al., 1989b) .
The current experiments were undertaken to test the hypothesis that glutamate uptake in astrocyte-rich cultures significantly alters the pharmacology of glutamate neurotoxicity in these cultures.
Materials and Methods
Tissue culture. Dissociated cell cultures derived from rat embryonic cerebral cortex were prepared as described previously (Rosenberg, 199 1) . Tissue was removed from embryonic day 16 CD rat fetuses, dissociated using trypsin, and plated on poly-L-lysine-or collagen plus poly-Llysine-coated glass coverslips. Astrocyte-rich cultures were grown in medium containing Dulbecco's modified Eagle's medium (DMEM), Ham's F-12, and calf serum (DHS; 8: 1: 1) containing 2 mM glutamine, penicillin and streptomycin, 25 mM HEPES, and 25 mM glucose. At 15 d in vitro, these cultures were exposed to 5 PM cytosine arabinoside for 72 hr. Astrocyte-poor cultures were grown in DHS for 4 d, at which point they were exposed to cytosine arabinoside for 48 hr. On day 7, medium was removed and replaced with a serum-free medium containing minimum essential medium (MEM), DMEM, and Ham's F-12 (5:4:1) with the N2 additives used by Bottenstein and Sato (1979) , in addition to catalase (Walicke et al., 1986) , penicillin and streptomycin, 2 mM glutamine, and 11 mM glucose. Medium was not subsequently changed in astrocyte-poor cultures, and they were placed on watersoaked filter paper pads to retard loss of water from the culture medium.
Toxicity experiments. Procedures were used that have been previously described (Rosenberg and Aizenman, 1989; Rosenberg, 199 1) . Astrocyte-rich cultures were washed once with physiological saline and then placed in wells containing MEM, plus selected concentrations of drugs. Wells were incubated for 30 min at 35°C in 5% CO, and, for most experiments, were gently agitated during this period. After exposure to drugs, medium was replaced with fresh medium, and cultures were returned to the incubator for 20-24 hr. Experiments with astrocyte-rich cultures were terminated by staining with trypan blue and fixing in 2.5% glutaraldehyde (Pixley and Cotman, 1985; Rosenberg, 1988) . Experiments with astrocyte-poor cultures were terminated in most experiments by fixation in 2.5% glutaraldehyde, since these cultures are damaged by repeated washing, and because dead cells in these cultures rapidly disintegrate, leaving few to pick up the trypan blue stain (Rosenberg and Aizenman, 1989) . Surviving neurons were counted in 10 fields per coverslip, using phase-contrast microscopy at 240 x magnification.
In sodium substitution experiments, the exposure medium was Trisbuffered saline (Choi, 1987) using sodium chloride, choline chloride, or lithium chloride.
Astrocyte-poor cultures were used at 18-40 d in vitro. Astrocyte-rich cultures were used at 27-68 d in vitro. For D-glutamate, three and four culture dates (individual platings) were used for the reported experiments with astrocyte-poor and astrocyte-rich cultures, respectively; for D-and L-aspartate, two and four culture dates were used for experiments with astrocyte-poor and astrocyte-rich cultures, respectively; three different dates were used for the L-glutamate experiments with astrocyterich cultures, seven for the L-glutamate experiments with astrocyte-poor cultures; three different dates for the NMDA experiments with both culture types; seven different dates for the sodium depletion experiments with astrocyte-rich cultures and four with astrocyte-poor cultures; and two different dates for the sodium depletion experiments with lithium replacement. Experiments were performed at least in duplicate and usually in triplicate or quadruplicate (Rosenberg, 199 1) .
Uptake experiments. The method of Drejer et al. (1985) was used for experiments, with the exception that the medium was MEM, the same as that for the toxicity experiments. 3H-D-aspartate (Amersham TRK.66, batch 23; specific activity, 33 Ci/mmol; adjusted to 0.5 pCi/nmol with nonradioactive D-aspartate) was used as the substrate for measuring uptake. After 5 min exposure, medium was taken and assayed for radioactivitv bv the method of liauid scintillation. Counting efficiencv was apprdximately 30%. Tissue was digested either with 2 & KOH 0; with 0.1 M NaOH. Tissue samples were Assayed for protein using the protein-dye binding method (Bradford, 1976 ) and a bovine serum albumin standard.
Results
The neurotoxic potencies of agonists that are and are not substrates for the glutamate uptake system were determined in astrocyte-rich and astrocyte-poor cultures. This allows for a direct test of the hypothesis that glutamate uptake is necessary for the difference in potency of glutamate as a neurotoxin in the two culture systems, exploiting the differences in the affinities for the glutamate uptake carrier of glutamate agonists. Brew and Attwell (1987) have shown the relative magnitude of inward currents evoked via the uptake carrier in retinal glial cells by L-glutamate, L-aspartate. D-aspartate, NMDA, and D-glutamate to be 1:0.43:0.25:0.06:0. The hypothesis predicts that transported agonists such as L-glutamate and D and L-aspartate should be more potent in astrocyte-poor cultures than in astrocyte-rich cultures, whereas weakly transported agonists such as Dglutamate or NMDA should show similar neurotoxic potencies in the two culture systems. Figure IA shows a typical dose-response experiment in which astrocyte-rich or astrocyte-poor cultures were exposed to L-glutamate for 30 min and then returned to MEM for 20-24 hr. As has been reported before, there was a marked increase in potency of glutamate as a neurotoxin in astrocyte-poor cultures. In contrast, Figure 1R shows a similar experiment that used the poorly transported agonist D-glutamate (Drejer et al., 1982; Brew and Attwell, 1987) . There was a similar response to this agonist in the two culture systems. D-and L-aspartate are both substrates for the glutamate transporter (Drejer et al., 1982; Brew and Attwell, 1987) . Both of these agonists showed a significant enhancement of neurotoxic potency in astrocyte-poor cultures (Fig.  2) .
The neurotoxic potencies of the weakly transported agonist NMDA in the two culture systems were compared (Fig. 3) . The EC,, values in the two culture systems were virtually identical. Table 1 summarizes all the data obtained with these agonists and includes, for comparison, data obtained from electrophysiological experiments (Patneau and Mayer, 1990) and binding experiments (Olverman et al., 1988) , as well as from previously reported studies using conventional astrocyte-rich murine cortical cultures Choi et al., 1989) .
Further support for the uptake hypothesis comes from experiments involving blockade of sodium-dependent glutamate uptake by removal of extracellular sodium (Fig. 4 A,B ; Table  2 ). Substitution of choline for sodium increased the potency of glutamate as a neurotoxin in astrocyte-rich cultures by approximately lOO-fold (Fig. 4A, Table 2 ), but had no significant effect on the potency of glutamate in astrocyte-poor cortical cultures (Fig. 4B, eliminated the difference in the potency of glutamate in the two culture systems and made astrocyte-rich cultures resemble astrocyte-poor cultures. Similarly, substitution of lithium for sodium also increased the potency of glutamate in astrocyte-rich cultures (14-fold, Table 2 ). The data presented so far can be explained best by the operation, in the astrocyte-rich cultures, of a glutamate uptake system that is substantially reduced in the astrocyte-poor cultures. We therefore sought to measure this function directly in the two culture systems using the nonmetabolizable substrate D-aspartate (Gordon and Balazs, 1983) , according to the method of Drejer et al. (1985) . At zero time, 3H-D-aspartate was added to a final concentration of 1 WM, and media and tissue samples were collected after 5 min. The results are shown in Table 3 . When the data were normalized on the basis of cell protein, the uptake measured in the astrocyte-rich cultures, which are 90- Data are mean EC,, vaIues GIM) for glutamate agonists in astrocyte-rich and astrocyte-poor cultures (30 min exposure) followed by 20-24 hr incubation in MEM. Data are given for rat astrocyte-rich (Rat AR) and rat astrocyte-poor (Rat AP) cortical cultures (present study), electrophysiological experiments in hippocampus (Phys), radioligand binding experiments (Binding), and murine astrocyte-rich cultures (Mouse AR) following 5 min or 24 hr exposure to agonists. 0 Physiology data from Patneau and Mayer (1990 The operation of glutamate uptake systems in the two culture types was assessed 0 1 10 100 1000 using the nonmetabolizable tracer )H-o-aspartate at 1 PM with a 5 min incubation. Uptake rates were calculated from the radioactivity depleted from the media and
from the known specific radioactivity in the media. The results are means + SEM of five individual experiments. y For comparison the data provided by Drejer et al. (1985) for cultures of astrocytes are also included. 95% astrocytes, was similar to what has been measured previously for astrocyte cultures. When the data were normalized on the basis of surface area covered by the culture, which is the most relevant measure for the purposes of the present study, the astrocyte-poor cultures demonstrated a 25-fold reduction in uptake [consistent with the fact that per unit area of culture there is approximately Y& the protein in astrocyte-poor cultures (10 rg/coverslip = 113 mmZ) compared to astrocyte-rich cultures (100 &coverslip)].
Discussion
These data provide strong support for the hypothesis that glutamate uptake, presumably by astrocytes, is required for the apparent reduction in potency of glutamate as a neurotoxin in astrocyte-rich cultures. In astrocyte-rich cultures, the order of potency of the glutamate agonists we tested was NMDA > D-glutamate = D-aspartate = L-aspartate > L-glutamate. This contrasts with the order of the potency series drawn from binding studies using 3H-aminophosphonovaleric acid (APV) (Olverman et al., 1988) : L-glutamate > L-aspartate = D-aspartate = NMDA > D-glutamate. The potency series of glutamate toxicity in astrocyte-rich cultures is also different from that obtained using electrophysiological responses in hippocampus (Patneau and Mayer, 1990) : L-glutamate > L-aspartate > NMDA. In contrast, neurotoxicity studies in astrocyte-poor cultures yield a potency series compatible with the data obtained by binding and electrophysiological studies: L-glutamate x D-aspartate = L-aspartate > NMDA > D-glutamate. Of note, however, in the neurotoxicity studies, the potencies of L-glutamate and the stereoisomers of aspartate were similar, whereas the binding and physiology studies show a 7-l l-fold higher potency of L-glutamate compared to aspartate. The present results are consistent with those obtained by Garthwaite (1985) , who compared the potency of glutamate agonists in cerebellar slices and in cell suspensions and showed that glutamate uptake disguises the pharmacology of glutamate agonist-stimulated cGMP accumulation in cerebellar slices. A diffusion model was developed to account for these results and predicted that, for any amino acid transported at the same rate as L-glutamate, and whose maximal response occurs at I 100 PM, an external concentration of approximately 1 mM would be required to produce a maximal effect, with an EC,, of approx- Astrocyte-poor 3.6 + 2 (n = 5) 2.2 + 0.9 (n = 5) -Astrocyte-rich 269 + 189 (n = 9) 2.6 f 2.7 (n = 7)
The neurotoxicity of glutamate (30 min exposure) in astrocyte-rich and astrocyte-poor cultures was compared with and without sodium present in the extracellular medium. The data presented are EC,, values &LM) for glutamate under the specified ionic and culture conditions. , which, by implication, may be assumed therefore to be largely determined by the transport properties of L-glutamate in astrocyte-rich cultures rather than the interaction of L-glutamate with its receptors. In contrast with GarthWaite's observations in the cerebellar preparations, we observed no differences in the potency of o-glutamate in astrocyte-poor and astrocyte-rich cultures. This suggests that the effects we observed were determined only by the high-affinity and not the low-affinity glutamate uptake system because o-glutamate is a substrate for the low-affinity uptake system (Benjamin and Quastel, 1976) . The hypothesis that glutamate uptake is responsible for the protection against glutamate toxicity observed in the astrocyterich cultures is further supported by the sodium replacement experiments. Substitution of choline for sodium resulted in a marked increase in the potency of L-glutamate in astrocyte-rich cultures without signljicantly affecting the potency of glutamate in the astrocyte-poor cultures. This argues strongly for sodiumdependent glutamate uptake as the primary mechanism determining the relative resistance to glutamate toxicity observed in the astrocyte-rich cultures. Since it has been proposed that the sodiumelcium exchange might have a protective role in circumstances that would challenge the ability of neurons to dispose of a calcium load (Mattson et al., 1989) , one might imagine an alternative explanation. The absence of a functional sodiumcalcium exchange system in neurons in the astrocyte-poor cultures might increase the neuronal vulnerability to glutamate seen in these cultures. Removal of sodium would inactivate the sodium-calcium exchange in astrocyte-rich cultures, rendering them more sensitive to glutamate, but would have no effect in the astrocyte-poor cultures. However, the similar potency of NMDA as a neurotoxin in the astrocyte-rich and astrocyte-poor cultures suggests that there is no difference in the intrinsic sensitivity ofcortical neurons maintained in the two culture systems to NMDA receptor-mediated toxicity.
The influence of growth conditions on sensitivity to excitotoxins is of concern, because the two culture types used for this work were maintained by different methods, necessitated by the difficulty in growing cortical neurons with few astrocytes present. This might conceivably result in a difference in intrinsic vulnerability to excitotoxicity, for example, if the astrocyte-poor culture conditions resulted in an increased expression of NMDA receptors on cortical neurons. We have addressed this issue previously, in showing similar electrophysiological responses to NMDA in cortical neurons in the two culture systems, suggesting similar expression of NMDA receptors. However, the strongest argument against the criticism that the history of the cultures produces an intrinsic difference in vulnerability to excitotoxicity is that the difference in vulnerability observed disappears when a nontransported agonist such as NMDA is used or when glutamate uptake is blocked (sodium-free medium). This argues that the difference is due to the glutamate uptake system, and not to an intrinsic difference in vulnerability that might be generated by differing culture conditions.
The fact that uptake appears to play an important role in the protection of neurons in the astrocyte-rich cultures requires that at least some portion of the neurons be isolated from direct exposure to the medium, since uptake would not be expected to be able to diminish the medium concentrations of agonists quickly enough to account for all of the protection observed. It is noteworthy, however, that some evidence has been obtained suggesting that astrocytes may lower glutamate concentrations in unstirred layers above them in culture (Sugiyama et al., 1989) . Since excitatory synapses are found primarily on dendrites (Peters et al., 199 l) , these would be likely to be the most sensitive and vulnerable element of the neuron to stimulation by excitatory agonists. Since neuronal processes are difficult to discern in the astrocyte-rich cultures, it is likely that they are buried under the astrocytes in this culture system. This prediction has been borne out in electron microscopic studies in the astrocyterich cultures (K. M. Harris and P. A. Rosenberg, unpublished observations). In contrast, neuronal processes in astrocyte-poor cultures are directly exposed to the medium.
Taken together, these observations argue for an important role for astrocytes in modulating the vulnerability of cortical neurons to glutamate toxicity, and specifically that sodium-dependent glutamate uptake is protective of neurons in vitro as well as in vivo (Coyle et al., 198 1; Mangano and Schwartz, 1983) .
By implication, it is likely that compromise ofastrocyte function by a variety of pathogenic mechanisms plays an important role in glutamate receptor-mediated neuronal injury and death.
